High‐Dose Chemotherapy in Relapsed or Refractory Metastatic Germ‐Cell Cancer: The Scotland Experience
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2018.11.013
Abstract: Purpose: To report outcomes from high‐dose chemotherapy (HDCT) and autologous stem‐cell transplantation (ASCT) for metastatic germ‐cell cancer in Scotland. Patients and Methods: All patients who underwent this treatment between the years 2001 and 2016 at… read more here.
Keywords: dose chemotherapy; metastatic germ; germ cell; cancer ... See more keywords
Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors.
Sign Up to like & getrecommendations! Published in 2018 at "European journal of cancer"
DOI: 10.1016/j.ejca.2018.01.113
Abstract: BACKGROUND For metastatic germ cell tumour patients with intermediate prognosis (IPGCT) according to the IGCCCG classification 5-year overall survival (OS) rates of 79% were described, but recent data suggest significant changes. PATIENTS AND METHODS To… read more here.
Keywords: prognosis; group; metastatic germ; intermediate prognosis ... See more keywords
A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy.
Sign Up to like & getrecommendations! Published in 2020 at "European urology focus"
DOI: 10.1016/j.euf.2020.09.017
Abstract: BACKGROUND It remains unclear which patients with metastatic germ cell tumours (mGCTs) need prophylactic anticoagulation to prevent venous thromboembolic events (VTEs). OBJECTIVE To assess the risk and onset of VTEs stratified by risk factors. DESIGN,… read more here.
Keywords: chemotherapy; anticoagulation; risk; prophylactic anticoagulation ... See more keywords
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021.
Sign Up to like & getrecommendations! Published in 2021 at "European urology"
DOI: 10.1016/j.eururo.2021.02.032
Abstract: Men with metastatic germ cell tumors undergoing chemotherapy are at high risk of venous thromboembolic events and low risk of bleeding. A central venous-access device should be avoided whenever possible. Thromboprophylaxis may be prescribed after… read more here.
Keywords: metastatic germ; central venous; germ cell; urology ... See more keywords